QNRX

Quoin Pharmaceuticals, Ltd. [QNRX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

QNRX Stock Summary

Top 10 Correlated Stocks

QNRX

In the News

QNRX Financial details

Company Rating
-
Market Cap
760.16K
Income
-8.49M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-0.55
Forward P/E
-
PEG
0.09
P/S
-
P/B
0.62
P/C
-
P/FCF
-0.72
Quick Ratio
3.05
Current Ratio
3.09
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-8.6
EPS next Y
-
EPS next Q
-
EPS this Y
-58.12%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
7.69%
-
-
-
-
SMA20
-
SMA50
50%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-56%
ROE
-96%
ROC
-0.85%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-778%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.74-12.0
52W High
-
52W Low
-
RSI
54
Rel Volume
-
Avg Volume
627.53K
Volume
2.56K
Perf Week
-6.27%
Perf Month
7.67%
Perf Quarter
1495.52%
Perf Half Y
1202.3%
-
-
-
-
Beta
1.953
-
-
Volatility
0.19%, 0.4%
Prev Close
3.64%
Price
9.12
Change
0.88%

Something similar

Top by Market Cap
LLY.DE
AMZN
GOOGL
MSFT
VOO
Same Sector
TRIL.TO
603718.SS
OCPNF
086450.KQ
SMSA
Top Correlated Stocks
BONHR.OL
ATER
TATT
NSKOG.OL
CTA-PB
Similar Market Cap
VISM
PVNNF
SMLE
ETCK
OTIC

Company Profile

Healthcare Biotechnology
  • Volume Average 627.53K
  • Market Capitalization 760.16K
  • Employee 4
  • CEO Dr. Michael Myers Ph.D.
  • Headquarters Ashburn,VA,US
  • IPO Date 2016-08-01
  • Website https://quoinpharma.com

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.